InflaRx appoints Gabriela Alperovich as SVP, global head of clinical development
IFRX•InflaRx appointed Gabriela Alperovich as senior vice president and global head of clinical development, effective Oct. 1, 2026.
1. Appointment details
Alperovich most recently served at CSL Vifor as executive director and global clinical lead for cardiovascular and renal programs. Her previous clinical development or medical affairs leadership roles included CSL Vifor, AbbVie and Bristol-Myers Squibb.
